SINGVAC SINGLE SHOT 5 IN 1 VACCINE FOR SHEEP AND LAMBS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

singvac single shot 5 in 1 vaccine for sheep and lambs

virbac (australia) pty ltd - clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - toxoid vaccine-toxoid active 0.0 u; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 iu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml; thiomersal mercury other 0.13 g/l - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | vaccine | clostridium perfringens type d | equine rotavirus | tetanus vaccination

Suiseng Each 2 mL (dose) contains: E. coli (F4ab fimbrial adhesin) E. coli (F4ac fimbrial adhesin) E. coli (F5 fimbrial adhesin) E. coli (F6 fimbrial adhesin) LT Enterotoxoid of E.coli B-Toxoid Clostridium perfringens, Type C á-Toxoid Clostridium novyi $5% ER * »78% ER70 59% ER30 80% ER25 5% ER 70 5% ERS >50% ER 120 Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

suiseng each 2 ml (dose) contains: e. coli (f4ab fimbrial adhesin) e. coli (f4ac fimbrial adhesin) e. coli (f5 fimbrial adhesin) e. coli (f6 fimbrial adhesin) lt enterotoxoid of e.coli b-toxoid clostridium perfringens, type c á-toxoid clostridium novyi $5% er * »78% er70 59% er30 80% er25 5% er 70 5% ers >50% er 120 suspension for injection (im)

hipra philippines, inc.; distributor: hipra philippines, inc. - escherichia coli fimbrial adhesins , e. coli lt enterotoxoid , clostridium perfringens b-toxoid , c. novyi type b a-toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: e. coli (f4ab fimbrial adhesin) e. coli (f4ac fimbrial adhesin) e. coli (f5 fimbrial adhesin) e. coli (f6 fimbrial adhesin) lt enterotoxoid of e.coli b-toxoid clostridium perfringens, type c á-toxoid clostridium novyi $5% er * »78% er70 59% er30 80% er25 5% er 70 5% ers >50% er 120

Toxipra Plus Formulation: Each 2 mL (dose) contains: Clostridium perfringens (Type B, C, and D) B Toxoid .................... > 10 IU/mL Clostridium perfringens (Type B, C, and D) e Toxoid............. >3.5 IU/mL Clostridium novyi (Type B) a Toxoid......... > 2.5 IU/mL Clostridium septicum a Toxoid ............. Clostridium chauvoei ............ ........... 100 % Protection Clostridium tetani Toxoid........... > 2.5 IU/mL Suspension for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

toxipra plus formulation: each 2 ml (dose) contains: clostridium perfringens (type b, c, and d) b toxoid .................... > 10 iu/ml clostridium perfringens (type b, c, and d) e toxoid............. >3.5 iu/ml clostridium novyi (type b) a toxoid......... > 2.5 iu/ml clostridium septicum a toxoid ............. clostridium chauvoei ............ ........... 100 % protection clostridium tetani toxoid........... > 2.5 iu/ml suspension for injection (im/sc)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated clostridium perfringens b and e , clostridium novyi a , clostridium septicum a , clostridium chauvoei , clostridium tetani vaccine (vet.) - suspension for injection (im/sc) - formulation: each 2 ml (dose) contains: clostridium perfringens (type b, c, and d) b toxoid .................... > 10 iu/ml clostridium perfringens (type b, c, and d) e toxoid............. >3.5 iu/ml clostridium novyi (type b) a toxoid......... > 2.5 iu/ml clostridium septicum a toxoid ............. clostridium chauvoei ............ ........... 100 % protection clostridium tetani toxoid........... > 2.5 iu/ml

Toxipra Plus Formulation: Each 2 mL[dose) contains: Clostridium perfringens (Type B, C and D) b Toxoid ->10 IU C. perfringens (Type B, C and D) e Toxoid-5IU Clostridium novyi (Type B) e Toxoid->5 IU Clostridium septicum a Toxoid-->5 IU Clostridium chauvoei- 100% protection Clostridium tetani-->5 IU Suspension For Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

toxipra plus formulation: each 2 ml[dose) contains: clostridium perfringens (type b, c and d) b toxoid ->10 iu c. perfringens (type b, c and d) e toxoid-5iu clostridium novyi (type b) e toxoid->5 iu clostridium septicum a toxoid-->5 iu clostridium chauvoei- 100% protection clostridium tetani-->5 iu suspension for injection (im/sc)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated clostridium perfringens b and € , clostridium novyi a , clostridium septicum a , clostridium chauvoei , clostridium tetani vaccine (vet.) - suspension for injection (im/sc) - formulation: each 2 ml[dose) contains: clostridium perfringens (type b, c and d) b toxoid ->10 iu c. perfringens (type b, c and d) e toxoid-5iu clostridium novyi (type b) e toxoid->5 iu clostridium septicum a toxoid-->5 iu clostridium chauvoei- 100% protection clostridium tetani-->5 iu

Suiseng Each 2 mL (dose) contains: Escherichia coli Fimbrial Adhesin F4ab F4ac F5 F6 %65% ER60 278% ER70 279% ER 50 >80% ER35 >55% ER 70 >35% ER25 >50% ER120 E. coli LT Enterotoxoid Clotridium perfringens (Type C) BToxoid Clostridium novyi (Type B) a Toxoid % ERx: Percentage of immunized rabbits with enzyme immunoassay response. Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

suiseng each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response. suspension for injection (im)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated escherichia coli fimbrial adhesin (f4ab, f4ac, f5 and f6) , heat labile (lt) enterotoxoid , clotridium perfringens (type c) b toxoid , clostridium novyi (type b) a toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response.

Novynette Tablet Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novynette tablet

pahang pharmacy sdn. bhd. - desogestrel; ethinylestradiol -

Novynta, 1.5 mg, tablets Malta - English - Medicines Authority

novynta, 1.5 mg, tablets

aflofarm farmacja polska sp. zo.o. ul. partyzancka 133/151 95-200 pabianice, poland - cytisine - tablet - cytisine 1.5 mg - other nervous system drugs

ULTRAVAC 7 IN 1 VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ultravac 7 in 1 vaccine

zoetis australia pty ltd - clostridium chauvoei - formol culture; leptospira interrogans serovar pomona; leptospira borgpetersenii serovar hardjo; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - misc. vaccines or anti sera - clostridium chauvoei - formol culture vaccine-microbial active 0.0 p; leptospira interrogans serovar pomona vaccine-microbial active 0.0 p; leptospira borgpetersenii serovar hardjo vaccine-microbial active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - black disease | blackleg | enterotoxaemia (pulpy kidney) | leptospirosis | malignant oedema | tetanus | clostridium perfringens type d | l. hardjo | l. interrogans | l. pomona | l. tarassovi | tetanus vaccination

WEBSTERS 6 IN 1 SE VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

websters 6 in 1 se vaccine

virbac (australia) pty ltd - selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid; thiomersal - misc. vaccines or anti sera - selenium as sodium selenate mineral-selenium active 1.0 mg/ml; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 iu/ml; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 iu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 1.0 iu/ml; thiomersal mercury other 0.13 mg/ml - immunotherapy - lamb | ovine - black disease | blackleg | cheesy gland | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | unthriftiness | white muscle disease | clostridium perfringens type d | ill - thrift | lymphadenitis | lymphangitis | selenium deficiency | selenium responsive ill-thrift | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination

WEBSTERS 5 IN 1 VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

websters 5 in 1 vaccine

virbac (australia) pty ltd - clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; sodium hydroxide 30%; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; sodium hydroxide 30% ungrouped other 0.0 qs ph; thiomersal mercury other 0.13 g/l - immunotherapy - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | clostridium perfringens type d | tetanus vaccination